These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 19731119

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
    Laan E, van Lunsen RH, Everaerd W.
    Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
    [Abstract] [Full Text] [Related]

  • 46. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

  • 47. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.
    Gynecol Endocrinol; 2004 May 10; 18(5):244-57. PubMed ID: 15346660
    [Abstract] [Full Text] [Related]

  • 48. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK, Ahn JY, Jin DK, Yoon BK, Kim HS, Kim DS, Kang WC, Han SH, Choi IS, Shin EK.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1889-94. PubMed ID: 12933531
    [Abstract] [Full Text] [Related]

  • 49. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH.
    Arch Intern Med; 2003 Oct 01; 156(15):1693-700. PubMed ID: 8694668
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D, Posea C, Ceausu I, Rusu M.
    Eur Rev Med Pharmacol Sci; 2003 Oct 01; 7(5):117-25. PubMed ID: 15214586
    [Abstract] [Full Text] [Related]

  • 53. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA, TOTAL Study Investigators Group.
    BJOG; 2007 Dec 01; 114(12):1522-9. PubMed ID: 17995496
    [Abstract] [Full Text] [Related]

  • 54. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
    Inan I, Kelekci S, Yilmaz B.
    Gynecol Endocrinol; 2005 Feb 01; 20(2):64-7. PubMed ID: 15823823
    [Abstract] [Full Text] [Related]

  • 55. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW.
    Menopause; 2006 Feb 01; 13(3):387-96. PubMed ID: 16735935
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
    Dedeoğlu EN, Erenus M, Yörük P.
    Fertil Steril; 2009 Feb 01; 91(2):425-31. PubMed ID: 18249383
    [Abstract] [Full Text] [Related]

  • 58. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P, Kimmig R, Kubista E, Biglia N, Egberts J, Mulder R, Planellas J, Moggio G, Mol-Arts M, Kenemans P.
    Maturitas; 2011 Dec 01; 70(4):365-72. PubMed ID: 22030384
    [Abstract] [Full Text] [Related]

  • 59. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM.
    JAMA Intern Med; 2017 Oct 01; 177(10):1471-1479. PubMed ID: 28846767
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.